Challenges and Limitations of Endocrine Toxicity Evaluation in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy—Retrospective Study from a Tertiary-Level Hospital in Romania

(1) Background: The endocrine system has become a prominent target to autoimmune damage during treatment with immune checkpoint inhibitors (ICIs) in cancer patients. Real-world data regarding endocrine immune-related adverse events (irAEs) are needed to explore their impact in cancer patients. An an...

Descripción completa

Detalles Bibliográficos
Autores principales: Coniac, Simona, Costache Outas, Mariana Cristina, Pirvu, Edvina-Elena, Patru, Raluca-Ileana, Gainariu, Estera, Aldea, Ciprian, Iorga, Polixenia Georgeta, Ambroci, Mihaela, Liscu, Horia-Dan, Miron, Andreea-Iuliana, Badiu, Corin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217146/
https://www.ncbi.nlm.nih.gov/pubmed/37238273
http://dx.doi.org/10.3390/diagnostics13101788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10217146/
https://www.ncbi.nlm.nih.gov/pubmed/37238273
http://dx.doi.org/10.3390/diagnostics13101788

Ejemplares similares